Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evaluation of the hypercalcemic patient

L R Reynolds, J A Flueck

    American Family Physician
    |April 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Malignancy is the leading cause of hypercalcemia, often linked to bone resorption. Primary hyperparathyroidism, frequently due to parathyroid adenoma, is also a significant factor.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Modification of the Bumpus forceps.

    Transactions. American Urological Association. Western Section·2010
    Same author

    Modification of the Bumpus forceps.

    The Journal of urology·2010
    Same author

    Measurement of velocity with a kinematic system versus a photocell system in the collection of canine ground reaction forces.

    Veterinary and comparative orthopaedics and traumatology : V.C.O.T·2007
    Same author

    Measurement differences between three versus five photocells during collection of ground reaction forces in dogs.

    Veterinary and comparative orthopaedics and traumatology : V.C.O.T·2007
    Same author

    Rosiglitazone amplifies the benefits of lifestyle intervention measures in long-standing type 2 diabetes mellitus.

    Diabetes, obesity & metabolism·2002
    Same author

    Reemergence of insulin pump therapy in the 1990s.

    Southern medical journal·2001

    Area of Science:

    • Endocrinology
    • Oncology
    • Nephrology

    Background:

    • Hypercalcemia is a complex metabolic disturbance with diverse etiologies.
    • Malignancy and primary hyperparathyroidism are leading causes of elevated serum calcium.
    • Understanding the mechanisms of hypercalcemia is crucial for diagnosis and management.

    Purpose of the Study:

    • To review the common causes of hypercalcemia.
    • To discuss the pathophysiology of calcium dysregulation in malignancy and endocrine disorders.
    • To highlight the impact of diagnostic advancements on disease recognition.

    Main Methods:

    • Literature review of hypercalcemia etiologies.
    • Analysis of pathophysiological mechanisms.
    • Discussion of clinical and biochemical findings.

    Related Experiment Videos

    Main Results:

    • Malignancy is the most frequent cause of hypercalcemia, acting via bone invasion or humoral factors.
    • Primary hyperparathyroidism incidence has risen due to automated screening, with parathyroid adenoma being the primary cause.
    • Sarcoidosis can cause hypercalciuria but rarely sustained hypercalcemia; increased 1,25-dihydroxycholecalciferol contributes to hypercalcemia.

    Conclusions:

    • Hypercalcemia necessitates a thorough diagnostic approach considering malignancy, primary hyperparathyroidism, and other less common causes.
    • Advances in biochemical screening have increased the detection of primary hyperparathyroidism.
    • Pathways involving bone resorption and vitamin D metabolism are key to hypercalcemia pathogenesis.